Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

Posted on by

Lancet Infectious Diseases
Jun 2021 Volume 21 Number 6 p743-888, e141-e181
https://www.thelancet.com/journals/laninf/issue/current

 

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
Ed Clarke, et al.
Open Access